---
title: "Haotian “Synco” Tang"
author: "Biostatistician | Statistical Geneticist"
output:
  html_document:
    theme: flatly
    toc: false
    css: styles.css  
---
```{=html}
<div class="container" style="
     margin-left: 0;
     margin-top: 20px;
     margin-bottom: 40px;
     background-color: rgba(255,255,255,0.9);
     padding: 20px;
     border-radius: 8px;
   ">
  <div class="row">
    <!-- PHOTO & CONTACTS -->
    <div class="col-md-3 text-left" style="margin-top:25px;">
      <img src="profile.jpg"
           alt="Haotian Tang"
           class="img-fluid rounded-circle mb-3">
      <ul class="list-unstyled">
        <li><strong>Email:</strong>
            <a href="mailto:syncotang@gmail.com">
              syncotang@gmail.com
            </a>
        </li>
        <li><strong>Phone:</strong> +86 15605512998</li>
        <li><strong>Affiliation:</strong>
            M.S. Biostatistics, Columbia University
        </li>
        <li><strong>ORCID:</strong>
            <a href="https://orcid.org/0009-0000-2410-9092" target="_blank">
              0009-0000-2410-9092
            </a>
        </li>
        <li><strong>LinkedIn:</strong>
            <a href="https://www.linkedin.com/in/syncotang/" target="_blank">
              syncotang
            </a>
        </li>
      </ul>
    </div>

    <!-- MAIN CONTENT (capped at 8/12 width) -->
    <div class="col-md-7">
      <h2>Education</h2>
      <p>
        I graduated from University of Toronto in 2022 with a focus on pharmacology, genome biology, and mathematics. During undergraduate, I was an exchange student at the the National University of Singapore and University of Oxford. I obtained my Master of Science in Biostatistics at Columbia University in 2025, specializing in statistical genetics. I will begin my PhD in 2026 with a focus on precision medicine through drug–genomics integration.
      </p>

      <h2>Publications</h2>
      <ul class="list-unstyled">
        <li>
          Hark, L.A., Gorroochurn, P., <strong>Tang, H.</strong>, <i>et al</i>.  
          Improvement in vision-related quality-of-life using the NEI-VFQ-9 over 1-year in the Manhattan Vision Screening and Follow-up Study (NYC-SIGHT).  
          Graefe’s Arch Clin Exp Ophthalmol (2025).  
          <a href="https://doi.org/10.1007/s00417-024-06727-z" target="_blank">
            https://doi.org/10.1007/s00417-024-06727-z
          </a>
        </li>
        <li style="margin-top:0.5em;">
          Morse, A.R., Hark, L.A., Seiple, W.H., Gorroochurn, P., <strong>Tang, H.</strong>, <i>et al</i>.  
          Association of behavioral factors with activation in patients with age-related macular degeneration or diabetic retinopathy.
          Clinical Ophthalmology (2025).  
          <a href="https://doi.org/10.2147/OPTH.S542352" target="_blank">
            https://doi.org/10.2147/OPTH.S542352 
          </a>
        </li>
        <li style="margin-top:0.5em;">
          Morse, A. R., Hark, L. A., Seiple, W., Gorroochurn, <strong>Tang, H.</strong>, <i>et al</i>.  
          Modifying locus of control beliefs may improve activation in patients with age-related macular degeneration or diabetic retinopathy.
          Investigative Ophthalmology & Visual Science (2025).  
          <a href="https://iovs.arvojournals.org/article.aspx?articleid=2805311 " target="_blank">
            https://iovs.arvojournals.org/article.aspx?articleid=2805311  
          </a>
        </li>
      </ul>
      
      
        <h2>Research Interests</h2>
  <p>
    Multidisciplinary studies associated with medicine and AI, precision medicine, genomics, pharmacology.
  </p>
        <h2>Resume</h2>
  <p>
      <a href="Resume.pdf" target="_blank" rel="noopener">
      Haotian Tang
  </p>
    </div>
  </div>
</div>


 
```


